If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNatwest Regulatory News (NWG)

Share Price Information for Natwest (NWG)

Share Price is delayed by 15 minutes
Get Live Data
651.40    -26.40 (-3.89%)
Bid:
652.80
Ask:
653.00
Spread: 0.20 (0.031%)
Market Cap: £51.85b
NWG Live PriceLast checked at - London Stock Exchange

Intraday Natwest Share Chart

Director/PDMR Shareholding

10 Mar 2025 14:00

RNS Number : 0409A
NatWest Group plc
10 March 2025
 

10 March 2025

NatWest Group plc

 

INITIAL NOTIFICATION OF TRANSACTIONS OF PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY (PDMRs) IN ACCORDANCE WITH ARTICLE 19 OF THE MARKET ABUSE REGULATION

 

1. NatWest Group plc (the Company) announces that conditional restricted share plan awards (RSP) and deferred awards (Deferred Awards) over ordinary shares of £1.0769* each in the Company (Shares) (ISIN: GB00BM8PJY71) have been granted on 7 March 2025 under the NatWest Group plc 2024 Employee Share Plan (the Plan) to the PDMRs set out below:

 

Name of PDMR

Position of PDMR

Award

Maximum no. of

Shares eligible to vest

 

Robert Begbie

CEO, NatWest Commercial & Institutional

RSP

278,153

Deferred Award2

50,812

Angela Byrne

Interim CEO, Retail Banking

Deferred Award1

41,094

Emma Crystal

CEO, Coutts and Wealth Businesses

RSP

217,489

Deferred Award2

44,305

Keiran Foad

Group Chief Risk Officer

RSP

326,234

Deferred Award2

57,339

Scott Marcar

Group Chief Information Officer

RSP

326,234

Deferred Award2

65,761

 Katie Murray

Group Chief Financial Officer

RSP

311,583

Deferred Award2

65,375

Paul Thwaite

Group Chief Executive Officer

RSP

451,682

Deferred Award2

97,215

Jen Tippin

Group Chief Operating Officer

RSP

326,234

Deferred Award2

65,701

The prices per Share used on the grant of the above awards were Deferred Awards1 £4.2431, Deferred Awards2 £4.5783 and RSP £3.7933. The prices are discounted to reflect the absence of dividend equivalents during the vesting period.

 

A pre-vest performance assessment will take place for the RSP at the end of three years. Subject to this, the RSP will be eligible to vest between 2028 and 2032. Deferred Awards will be eligible to vest between 2025 and 2030.

 

Malus provisions will apply to each award up until vesting and clawback provisions will apply for a period of seven years from the date of grant. Such period can be extended to ten years in certain circumstances. Vested Shares retained after payment of associated tax liabilities will be subject to a twelve-month retention period. 

2. The Company announces that long term incentive awards (LTI), Deferred Awards and Buy-out Awards over Shares vested on 7 March 2025 to the PDMRs set out below. The awards were granted under the Plan between March 2019 and August 2024. The number of Shares withheld to meet associated tax liabilities arising on vesting and the number of vested Shares retained by each PDMR is set out below:

 

Name of PDMR

Position of PDMR

Award

No. of Shares vested

No. of Shares withheld to satisfy associated tax liability

 

No. of vested Shares retained

 

Robert Begbie

 

CEO, NatWest Commercial & Institutional

 

LTI

 

149,999

75,113

74,886

Deferred Award

38,942

19,501

19,441

Angela Byrne

Interim CEO, Retail Banking

Deferred Award

15,747

7,413

8,334

Emma Crystal1

CEO, Coutts and Wealth Businesses

Buy-out Award

41,909

19,727

22,182

Keiran Foad1

Group Chief Risk Officer

Buy-out Award

100,196

47,163

53,033

Scott Marcar1

Group Chief Information Officer

Buy-out Award

130,451

61,405

69,046

 

Katie Murray

 

Group Chief Financial Officer

 

LTI

 

326,943

153,895

173,048

 

Deferred Award

 

41,790

19,671

22,119

 

Paul Thwaite

Group Chief Executive Officer

 

LTI

 

130,230

61,301

68,929

Deferred Award

30,123

14,180

15,943

Jen Tippin1

 

 

Group Chief Operating Officer

LTI

144,576

68,053

76,523

 

Deferred Award

97,743

46,009

51,734

Buy-out Award

159,985

75,306

84,679

1. Vested Shares retained after payment of associated tax liabilities will be subject to retention periods which mirror the retention periods applicable to the PDMR's awards granted by their previous employer.

 

The market price used to meet associated tax liabilities was £4.5761.

 

Vested Shares retained after payment of associated tax liabilities will be subject to retention periods of twelve months, unless otherwise indicated in the table above.

 

3. The Company announces that Shares were delivered to PDMRs on 7 March 2025, as set out below. The Shares delivered represent payment of a fixed share allowance for the three-month period ending 31 March 2025 and have been calculated using a share price of £4.7284.

 

The number of Shares delivered, the number of Shares withheld to meet associated tax liabilities and the number of Shares retained by each PDMR is as follows:

 Name of PDMR

Position of PDMR

No. of Shares delivered

No. of Shares withheld to satisfy associated tax liability

No. of Shares retained

Robert Begbie

CEO, NatWest Commercial & Institutional

19,167

9,598

9,569

Emma Crystal

CEO, Coutts and Wealth Businesses

14,540

6,844

7,696

Keiran Foad

Group Chief Risk Officer

21,810

10,266

11,544

Scott Marcar

Group Chief Information Officer

21,810

10,266

11,544

Katie Murray

Group Chief Financial Officer

41,661

19,610

22,051

Paul Thwaite

Group Chief Executive Officer

61,103

28,761

32,342

Jen Tippin

Group Chief Operating Officer

21,810

10,266

11,544

 

The market price used to determine the number of Shares withheld to meet associated tax liabilities was £4.5761. Shares retained after payment of associated tax liabilities will be held on behalf of PDMRs and will be released in instalments over a five year period.

All of the above transactions took place on the London Stock Exchange (XLON).

 

* Note: the nominal value of ordinary shares without rounding is £1.076923076923077 per share 

 

Legal Entity Identifier: 2138005O9XJIJN4JPN90

 

For further information contact:

NatWest Group Investor RelationsClaire KaneDirector of Investor Relations+44 20 7672 1758

 

NatWest Group Media Relations 

+44(0)131 523 4205

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSFIFESEISEFD
Date   Source Headline
6th Mar 20235:59 pmRNSTransaction in Own Shares
3rd Mar 20235:33 pmRNSTransaction in Own Shares
2nd Mar 20235:43 pmRNSTransaction in Own Shares
2nd Mar 202311:16 amRNSTR-1: Notice of Major Holdings
1st Mar 20235:44 pmRNSTransaction in Own Shares
28th Feb 20235:37 pmRNSTransaction in Own Shares
28th Feb 20234:20 pmRNSTotal Voting Rights
28th Feb 202311:51 amRNSNatWest Group plc Filing of Registration Statement
27th Feb 20235:28 pmRNSTransaction in Own Shares
27th Feb 20237:00 amRNSFiling of Annual Report on Form 20F with US SEC
24th Feb 20235:56 pmRNSTransaction in Own Shares
24th Feb 20234:59 pmRNSPublication of Final Terms
23rd Feb 20235:51 pmRNSTransaction in Own Shares
22nd Feb 20235:34 pmRNSTransaction in Own Shares
22nd Feb 20239:30 amRNSTR1 - Notification of major holdings
21st Feb 20235:46 pmRNSTransaction in Own Shares
21st Feb 20232:00 pmRNSDirector/PDMR Shareholding
20th Feb 20235:33 pmRNSTransaction in Own Shares
20th Feb 20237:00 amRNSCommencement of On Market Share Buyback Programme
17th Feb 20235:18 pmRNSPublication of Supplementary Prospectus
17th Feb 20237:00 amRNSAnnual Financial Report - NatWest Markets NV
17th Feb 20237:00 amRNSAnnual Financial Report - NatWest Group plc
17th Feb 20237:00 amRNSFinal Results - NatWest Group plc
3rd Feb 202310:49 amRNSTR-1: Notification of Major Holdings
31st Jan 202311:59 amRNSTotal Voting Rights and Capital
31st Jan 202310:00 amRNSDirectorate Change
17th Jan 202310:16 amRNSTR1 - Notification of Major Holdings
30th Dec 202211:38 amRNSTotal Voting Rights and Capital
21st Dec 202210:04 amRNSTR-1: Notification of Major Holdings
16th Dec 20229:33 amRNSDirectorate Change
7th Dec 20225:36 pmRNSPublication of a Prospectus
2nd Dec 20224:37 pmRNSPublication of Final Terms
30th Nov 20223:02 pmRNSTotal Voting Rights
25th Nov 20222:00 pmRNSDirector/PDMR Shareholding
24th Nov 202211:00 amRNSDirector Declaration
23rd Nov 20224:08 pmRNSDividend Declaration
11th Nov 20227:00 amRNSQ3 2022 Pillar 3 Supplements
10th Nov 20223:53 pmRNSDirector/PDMR Shareholding
8th Nov 20224:55 pmRNSHolding(s) in Company
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
4th Nov 202211:19 amRNSPricing of USD 7.472% Senior Callable Notes
31st Oct 20223:35 pmRNSTotal Voting Rights
28th Oct 20225:52 pmRNSPublication of Suppl.Prospcts
28th Oct 20227:00 amRNSNWG Q3 IMS Interim Management Statement 2022
20th Oct 20229:00 amRNSNatWest and Vodeno Create Strategic Partnership
5th Oct 20221:51 pmRNSBlock listing six monthly return
30th Sep 20222:15 pmRNSDirectorate Change
30th Sep 202212:45 pmRNSTotal Voting Rights
26th Sep 20225:44 pmRNSPublication of Suppl.Prospcts
26th Sep 20223:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.